—European drug chemical makers active as they head into annual U.S. conclave “More acquisition and expansion is expected in a booming, consolidating market” TThe European fine chemicals sector steamed into this week’s DCAT Week, a pharmaceutical service event held each year in New York City, with signs of continued strength. Siegfried, which has grown through a string of acquisitions to become one of the largest contract development and manufacturing organizations, announced it is buying back a finished-dose drug facility near its headquarters in Zofingen, Switzerland, that it sold to Arena Pharmaceuticals in 2017. Arena manufactured Belviq, a weight-loss drug, in Zofingen and provided services to Siegfried and other customers.
by Rick Mullin |
March 19, 2018